Patent

IP protection might just save the tech companies from their crisis

29.08.22 | James Spiro

Israeli companies and entrepreneurs should prepare for change in the European patent system

03.03.22 | Guillaume Stern

IP not as a burden, but rather as a crucial business tool

08.11.21 | Saleit Shahar

"When you're an entrepreneur, you're always on display. You're always performing, and you're always questioning how the audience is receiving you"

31.12.20 | CTech

How will Pfizer and Moderna protect their vaccine patent applications?

25.11.20 | Adv. Ephraim Heiliczer

Reinhold Cohn and Calcalist to host 2021 startup competition

15.11.20 | CTech

Five patents you should know about for Halloween 2020

29.10.20 | Adv. Nathan Renov

The lawyer who forges Israeli tech companies’ prized weapons

23.10.20 | Allon Sinai

Israel Patent Office mulls U.S.-inspired provisional application

15.06.20 | Hagar Ravet

As the pandemic continues to rage, patents should be protected without hampering innovation

08.06.20 | Chavah Apfelbaum and Syvanne Aloni

Teva Settles Patent Litigation Case for Blood Sugar Stabilizer With Novo Nordisk

24.03.19 | CTech

Teva Agrees to Stop Selling Amgen Generic Following Patent Infringement Settlement

03.01.19 | Lilach Baumer

Teva Reaches Confidential Patent Settlement with Neos

27.12.18 | CTech

Teva's Swiss Anti-Nausea Drug Patent Suit Reaches U.S. Supreme Court

05.12.18 | Lilach Baumer

Israelis Registered Fewer Patents, Scientific Discoveries in 2017

27.08.18 | Meir Orbach

Scientist Quarrel Over Kite Pharma Sale Royalties to be Settled Out of Court

28.05.18 | Zohar Shahar Levy

Scientist’s Ex-Wife Joins Legal Melee Over Kite Pharma Windfall

16.01.18 | Zohar Shahar Levy

Immunologists Exchange Verbal Blows in Legal Fight Over Kite Pharma Windfall

26.12.17 | Zohar Shahar Levy

Teva's Blockbuster Drug Takes Another Generic Blow

26.10.17 | Lilach Baumer

Startup Contests Are Not for Everyone

22.10.17 | Zachi Zach

Teva’s Stock Drops After Approval of Copaxone Competitors

08.10.17 | Lilach Baumer

Your First Investor Meeting, a Survival Guide

27.09.17 | Zachi Zach